The Taming of Capsaicin
Journal of Medicinal Chemistry, 2005, Vol. 48, No. 14 4669
13C NMR) of all target compounds and key intermediates. This
(16) Constant, H. L.; Cordell, G. A.; West, D. P. Nonivamide, a
Constituent of Capsicum Oleoresin. J. Nat. Prod. 1996, 59, 425-
426. Nonivamide is a common adulterant of commercial Capsi-
cum oleoresin, and samples containing greater than 3% noni-
vamide are considered as adulterated.
(17) Phenolic hydroxyls can have an inhibitory effect on aromatic
iodination. For a discussion, see: Jain, A. C.; Sarpal, P. D.;
Seshadri, T. R. Action of Iodine and Silver Acetate on Fla-
vanones. Proc. Indian Acad. Sci. Sect. A 1965, 42, 293-306.
(18) Janssen, D. E.; Wilson, C. V. Org. Syntheses, Wiley: New York,
Collect. Vol. IV, 1963; pp 547-549.
(19) Bovicelli, P.; Bernini, R.; Antonioletti, R.; Mincione, E. Selective
Halogenation of Flavanones. Tetrahedron Lett. 2002, 43, 5563-
5567.
(20) (a) Raiford, L. C.; Stoesser, W. C. New Bromine Substitution
Products of Vanilllin and some of their Derivatives. J. Am. Chem.
Soc. 1928, 50, 2556-2563. (b) Freudenberg, K.; Jovanoviæ, V.
Weitere Versuche mit deuteriertem Coniferylalkohol. Chem. Ber.
1963, 96, 2178-2181.
(21) Lawson, T.; Gannett, P. The Mutagenicity of Capsaicin and
Dihydrocapsaicin in V79 Cells. Cancer. Lett. 1989, 48, 109-113.
(22) Melck, D.; Bisogno, T.; De Petrocellis, L.; Chuang, H.-H.; Julius,
D.; Bifulco, M.; Di Marzo, V. Unsaturated Long-chain N-Acyl-
vanillyl-amides (N-AVAMs): Vanilloid Receptor Ligands that
Inhibit Anandamide-Facilitated Transport and Bind to CB1
Cannabinoid Receptor. Biochem. Biophys. Res. Commun. 1999,
262, 275-284.
(23) Appendino, G.: Minassi, A.; Schiano Morello, A.; De Petrocellis,
L.; Di Marzo, V. N-Acylvanillamides: Development of an Expe-
ditious Synthesis and Discovery of New Acyl Templates for
Powerful Activation of the Vanilloid Receptors. J. Med. Chem.
2002, 45, 3739-3745.
(24) The only natural product for which vanilloid antagonism was
reported is the guaianolide thapsigargin (To´th, A.; Kedei, N.;
Szabo´, T.; Wang, Y.; Blumberg, P. M. Thapsigargin Binds to and
Inhibits the Cloned Vanilloid Receptor-1. Biochem. Biophys. Res.
Commun. 2002, 293, 777-782).
(25) Guerrini, R.; Calo`, G.; Bigoni, R.; Rizzi, D.; Rizzi, A.; Zucchini,
M.; Varani, K.; Hashiba, E.; Lambert, D. G.; Toth, G.; Borea, P.
A.; Salvadori, S.; Regoli, D. Structure-Activity Studies on Phe4
residue of Nociceptin (1-13)-NH2: Identification of Highly
Potent Agonists of the Nociceptin(orphanin) FQ Receptor. J.
Med. Chem. 2001, 44, 3956-3964
(26) For a previous report on the antagonistic activity of some
halononivamides, see: Appendino, G.; Harrison, S.; De Petro-
cellis, L.; Daddario, N.; Bianchi, F.; Schiano Morello, A.; Tre-
visani, M.; Benvenuti, F.; Geppetti, P.; Di Marzo, V. Halogena-
tion of a Capsaicin Analgoue Leads to Novel Vanilloid TRPV1
Receptor Antagonists. Brit. J. Pharmacol. 2003, 139, 1417-1424.
(27) (a) Ochi, T.; Takaishi, Y.; Kogure, K.; Yamauti, I. Antioxidant
activity of a new capsaicin derivative from Capsicum annuum.
J. Nat. Prod. 2003, 66, 1094-1096. (b) Bernal, M. A.; Barcelo´,
A. R. 5, 5′-Dicapsaicin, 4′-O-5-Dicapsaicin Ether, and Dehydro-
genation Polymers with High Molecular Weights are the Main
Products of the Oxidation of Capsaicin by Peroxidase from Hot
Pepper. J. Agric. Food Chem. 1996, 44, 3085-3089.
(28) Chou, M. Z.; Mtui, T.; Gao, Y.-D.; Kohler, M.; Middleton, R. E.
Resiniferatoxin Binds to the Capsaicin Receptor (TRPV1) Near
the Extracelllular Side of the S4 Transmembrane Domain.
Biochemistry 2004, 43, 2501-2511.
(29) Olajos, E. J.; Salem, H. Riot Control Agents: Pharmacology,
Toxicoloty, Biochemistry and Chemistry. J. Appl. Toxicol. 2001,
21, 355-391.
(30) Suzuki, T.; Iwai, K. Constituents of Red Pepper Species: Chem-
istry, Biochemistry, Pharmacology, and Food Science of the
Pungent Principle of Capsicum Species. In The Alkaloids; Brossi,
A. Ed.; Academic Press: Orlando, FL, 1984;, Vol. 23, pp 227-
299.
(31) Mun˜oz, E.; Appendino, G.; De Petrocellis, L.; Di Marzo, V.
Manuscript in preparation.
(32) van der Stelt, M.; Di Marzo, V. Endovanilloids. Putative En-
dogenous Ligands of Transient Receptor Potential Vanilloid 1
Channels. Eur. J. Biochem. 2004, 271, 1827-1834.
(33) Toth, A.; Wang, Y.; Kedei, N.; Tran, R.; Pearce, L. V.; Kang, S.
U.; Jin, M. K.; Choi, H. K.; Lee, J.; Blumberg, P. M. Different
Vanilloid Agonists Cause Different Patterns of Calcium Re-
sponse in CHO Cells Heterologously Expressing Rat TRPV1. Life
Sci. 2005, 76, 2921-2932.
References
(1) Szallasi, A.; Blumberg, P. M. Vanilloid (Capsaicin) Receptors and
Mechanisms. Pharmacol. Rev. 1999, 51, 159-211.
(2) Szallasi, A. Vanilloid Receptor Ligands. Hopes and Realities for
the Future. Drugs Aging 2001, 18, 561-573.
(3) Cortright, D. N.; Szallasi, A. Biochemical Pharmacology of the
Vanilloid Receptor TRPV1. An Update. Eur. J. Biochem. 2004,
271, 1814-1819.
(4) (a) Appendino, G.; Mun˜oz, E.; Fiebich, B. TRPV1 (Vanilloid
Receptor, Capsaicin Receptor) Agonists and Antagonists. Exp.
Opin. Ther. Pat. 2003, 13, 1825-1837. (b) Plannels-Cases, R.;
Garcia-Martinez, C.; Royo, M.; Perez-Paya, E.; Carreno, C.;
Albericio, F.; Messeguer, A.; Ferrer-Montiel, A. Small Molecules
Targeting the Vanilloid Receptor Complex as Drugs for Inflam-
matory Pain. Drugs Future 2003, 28, 787-795.
(5) Szallasi, A.; Appendino, G. Vanilloid receptor TRPV1 Antago-
nists as the Next Generation of Painkillers. Are we Putting the
Cart Before the Horses? J. Med. Chem. 2004, 47, 2717-2723.
(6) (a) Bevan, S.; Hothi, S.; Hughes, G.; James, I. F.; Rang, H. P.;
Shah, K.; Walpole, C. S.; Yeats, J. C. Capsazepine: a Competi-
tive Antagonist of the Sensory Neuron Excitant Capsaicin. Br.
J. Pharmacol. 1992, 107, 544-552. (b) Walpole, C. S. J.; Bevan,
S.; Bovermann, G.; Boelsterli, J. J.; Breckenridge, R.; Davies, J.
W.; Hughes, G. A.; James, I.; Oberer, L.; Winter, J.; Wriggles-
worth, R. The Discovery of Capsazepine, the First Competitive
Antagonist of the Sensory Neuron Excitants Capsaicin and
Resiniferatoxin. J. Med. Chem. 1994, 37, 1942-1954.
(7) Wahl, P.; Foged, C.; Tullin, S.; Thomsen, C. Iodo-resiniferatoxin,
a new Potent Vanilloid Receptor Antagonist. Mol. Pharmacol.
2001, 59, 9-15.
(8) McDonnel, M. E.; Zhang, S.-P.; Dubin, A. E.; Dax, S. L. Synthesis
and in vitro Evaluation of a Novel Iodinated Resiniferatoxin
Derivative that is an Agonist at the Human Vanilloid VR1
Receptor. Bioorg. Med. Chem. Lett. 2002, 12, 1189-1192.
(9) Lee, J.; Lee, J.; Kang, M.; Shin, M.; Kim, J.-M.; Kang, S.-U.;
Lim, J.-O.; Choi, H.-K.; Suh, Y.-G.; Park, H.-G.; Oh, U.; Kim,
H.-D.; Park, Y.-H.; Lundberg, D. J.; Blumberg, P. M. N-(3-
Acyloxy-2-benzylpropyl)-N′-[4-(methylsulfonylamino)benzyl]th-
iourea Analogues: Novel Potent and High Affinity Antagonists
and Partial Antagonists of the Vanilloid Receptor. J. Med. Chem.
2003, 46, 3116-3126.
(10) Phillips, E.; Reeve, A.; Bevan, S.; McIntyre, P. Identification of
Species-specific Determinants of the Action of the Antagonist
Capsazepine and the Agonist PPAHV on TRPV1. J. Biol. Chem.
2004, 279, 217165-17172.
(11) Ullrich, T.; Baumann, K.; Welzenbach, K.; Schmutz, S. Cam-
enisch, G.; Meinganner, J. G.; Weitz-Schmidt, G. Statin-derived
1,3-Oxazinan-2-ones as Submicromolar Inhibitors of LFA-1/
ICAM-1 Interaction: Stabilization of the Metabolically Labile
Vanillyl Side Chain. Bioorg. Med. Chem. Lett. 2004, 14, 2483-
2487.
(12) Due to a pro-quinoid nature, vanillamides are oxidatively cleaved
by DDQ. The reaction has been used for the identification and
quantization of the acyl moieties of capsaicinoids in Capsicum
oleoresin (Markai, S.; Marchand, P. A.; Mabon, F.; Baguet, E.;
Billault, I.; Ronbins, R. J. Natural Deuterium Distribution in
Branched-chain Medium-length Fatty acids is Nonstatistical: A
Site-specific Study by Quantitative 2H NMR Spectroscopy of the
Fatty Acids of Capsaicinoids. ChemBioChem 2002, 3, 212-218).
(13) Appendino, G.; De Petrocellis, L.; Trevisani, M.; Minassi, A.;
Daddario, N.; Schiano-Morello, A.; Mazzieri, D.; Ligresti, A.;
Campi, B.; Fontana, G.; Pinna, C.; Geppetti, P.; Di Marzo, V.
Development of the First Ultrapotent Capsaicinoid Agonist at
Transient Receptor Potential Type (TRPV1) Channels and its
Therapeutic Potential. J. Pharmacol. Exp. Ther. 2005, 312, 561-
570.
(14) Nakamura, T.; Ooi, T.; Kogure, K.; Nishimura, M.; Terada, H.;
Kusumi, T. Structures of the Radical (DPPH) Oxidation Products
of Dihydrocapsaicin. Tetrahedron Lett. 2002, 43, 8181-8183.
(15) (a) Janusz, J. M.; Buckwalter, B. L.; Young, P. A.; LaHann, T.
R.; Farmer, R. W.; Kasting, G. B.; Loomans, M. E.; Kerckaert,
G. A.; Maddin, C. S.; Berman, E. F.; Bohne, R. L.; Cupps, T. L.;
Milstein, J. R. Vanilloids. 1. Analogues of Capsaicin with
Antinociceptive and Antiinflammatory Activity. J. Med. Chem.
1993, 36, 2595-2604. (b) Reilly, C. A.; Ehlhardt, W. J.; Jackson,
D. A.; Kulanthaivel, P.; Mutlib, A. E.; Espina, R. J.; Moody, D.
E.; Crouch, D. J.; Yost, G. S. Metabolism of Capsaicin by
Cytochrome P450 Produces Novel Dehydrogenated Metabolites
and Decreases Toxicity to Lung and Liver Cells. Chem. Res.
Toxicol. 2003, 16, 336-349.
JM050139Q